Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Lymphoma

Trial PRiZM+
Cancer Type Haematological Cancers and Lymphoma
Hospital(s) Belfast City Hospital
Information

A phase II platform study of zanubrutinib monotherapy and combination therapy for relapsed and refractory primary CNS lymphoma

Click Here to view Cancer Research UK trial summary
Trial REFRACT
Cancer Type Haematological Cancers and Lymphoma
Hospital(s) Belfast City Hospital
Information

A randomised phase II trial of investigator choice standard therapy versus sequential novel therapy experimental arms in relapsed and refractory follicular lymphoma

Click Here to view Cancer Research UK trial summary
Trial STELLAR
Cancer Type Haematological Cancers and Lymphoma
Hospital(s) Belfast City Hospital
Information

A phase II, randomiSed study of CHOP-R in combination with acalabruTinib comparEd to CHOP-R in patients with newLy diagnosed Richter’s Syndrome and a pLAtfoRm for initial investigations into activity of novel treatments in relapsed/refractory and newly diagnosed Richter’s Syndrome

Also in this Section